Goodwin

Dasol Lee

Deals
5
Latest
Jun 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 5 deals
Deals by year
Dasol Lee: deals by year0520252026 YTD: 5 M&A52026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Dasol Lee was named on, most recent first
Jun 2026 Topaz Labs –AdobeAcquisitionLegal adviser to Topaz Labs (target)Announced–AIAdobe acquisition of Topaz Labs
Jun 2026 Vendr –Vertice TechnologyAcquisitionLegal adviser to Vendr (target)Announced–SaaS+1Vertice Technology acquisition of Vendr
May 2026 Perfuse Therapeutics –BayerAcquisitionLegal adviser to Perfuse Therapeutics (target)Announced300.0Biotech+2Bayer acquisition of Perfuse Therapeutics
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Kelonia Therapeutics (target)Announced7,000.0Biotech+2Eli Lilly and Company acquisition of Kelonia Therapeutics
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis

Deals where Dasol Lee is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.